Our dedicated team in Bethlehem, Pennsylvania ensures you already know your coverage benefits before embarking on treatment, eliminating confusion about whether insurance covers semaglutide
The GLP-1/GIP dual agonist, HRS9531, from Hengrui, reported positive Phase 3 results in weight loss, and is the second (after Innovent) Chinese company to submit marketing authorisation for an obesity asset
The timeline for a study focused on accelerated tissue repair is going to look dramatically different from one exploring long-term anti-aging markers
During your consultation, well ask if youd like us to explore your coverage options
sugar, salt, dairy, yeast, wheat, gluten, corn, soy, preservatives, artificial colors or flavors